Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	138	45	60	53	198	-
Market Cap Growth	171.43%	-23.95%	12.22%	-73.09%	-	-
Enterprise Value	114	99	63	26	197	-
Last Close Price	1.05	0.82	1.41	1.36	5.37	-
PS Ratio	20.08	10.45	24.58	141.08	395.33	-
PB Ratio	5.35	8.42	-25.83	2.31	3.61	-
P/TBV Ratio	-	-	-	2.71	3.61	-
EV/Sales Ratio	25.98	22.71	25.79	68.61	394.82	-
Debt / Equity Ratio	0.94	3.94	-6.60	0.09	-	-
Asset Turnover	0.12	0.15	0.08	0.01	0.02	-
Inventory Turnover	12.23	22.94	30.74	11.97	0.88	-
Quick Ratio	1.87	1.01	0.71	2.83	12.90	0.02
Current Ratio	1.90	1.07	0.75	2.89	13.45	0.09
Return on Equity (ROE)	-331.24%	-2956.43%	-507.97%	-144.42%	-136.23%	-
Return on Assets (ROA)	-79.17%	-99.28%	-101.38%	-76.84%	-56.01%	-320.54%
Return on Capital (ROIC)	-86.25%	-145.41%	-159.52%	-88.13%	-83.15%	-
Return on Capital Employed (ROCE)	-177.80%	-640.40%	2295.50%	-233.60%	-50.10%	61.30%
Earnings Yield	-47.61%	-100.30%	-88.24%	-105.61%	-14.21%	-
FCF Yield	-31.95%	-97.89%	-55.35%	-57.52%	-9.38%	-
Buyback Yield / Dilution	-80.04%	-20.98%	-15.44%	-94.44%	-31.81%	-0.03%

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q